1. Federal State Statistics Service. Death statistics according to Rosstat. Available at: https://rosinfostat.ru/smertnost/#i-4. 2018.2018.
2. Roffi M, Patrono C, Collet J-P, Mueller C, Valgimigli M, Andreotti F et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). European Heart Journal. 2016;37(3):267–315. DOI: 10.1093/eurheartj/ehv320
3. Feldman L, Steg PG, Amsallem M, Puymirat E, Sorbets E, Elbaz M et al. Editor’s Choice-Medically managed patients with non–ST-elevation acute myocardial infarction have heterogeneous outcomes, based on performance of angiography and extent of coronary artery disease. European Heart Journal: Acute Cardiovascular Care. 2017;6(3):262–71. DOI: 10.1177/2048872615626354
4. Maddox TM, Reid KJ, Rumsfeld JS, Spertus JA. One-year health status outcomes of unstable angina versus myocardial infarction: a prospective, observational cohort study of ACS survivors. BMC Cardiovascular Disorders. 2007;7(1):28. DOI: 10.1186/1471-2261-7-28
5. Kaul P, Savu A, Hamza S, Knudtson ML, Bainey K, Brass N et al. Outcomes of medically managed patients with myocardial infarction. European Heart Journal: Acute Cardiovascular Care. 2019;8(6):571–81. DOI: 10.1177/2048872618812135
6. Sanchis-Gomar F, Perez-Quilis C, Leischik R, Lucia A. Epidemiology of coronary heart disease and acute coronary syndrome. Annals of Translational Medicine. 2016;4(13):256–256. DOI: 10.21037/atm.2016.06.33
7. Vagnarelli F, Taglieri N, Ortolani P, Norscini G, Cinti L, Bacchi Reggiani ML et al. Long-Term Outcomes and Causes of Death After Acute Coronary Syndrome in Patients in the Bologna, Italy, Area. The American Journal of Cardiology. 2015;115(2):171–7. DOI: 10.1016/j.amjcard.2014.10.019
8. Erdem G, Bakhai A, Taneja AK, Collinson J, Banya W, Flather MD. Rates and causes of death from non-ST elevation acute coronary syndromes: Ten year follow-up of the PRAIS-UK registry. International Journal of Cardiology. 2013;168(1):490–4. DOI: 10.1016/j.ijcard.2012.09.160
9. Berns S.A., Shmidt E.A., Nagirnyak O.A., Klimenkova A.V., Litvinova M.N., Sergeeva T.Yu. et al. Assessment of Outcomes and Treatment Tactics in Patients with Non-ST-Elevation Acute Coronary Syndrome: Data of Five-Year Follow-up. Kardiologiia. 2018;17(7):32–40.. DOI: 10.18087/cardio.2018.7.10141
10. Vershinina E.O., Repin A.N., Ryabova T.R. The impact of multifocal atherosclerosis on the early and late outcomes of planned endovascular treatment of ischemic heart disease. Siberian Medical Journal (Tomsk). 2014;29 (3):87–93.
11. Güneri S. Interventional therapy indications in the elderly – are they different? Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology. 2017;45(Suppl 5):39–41. DOI: 10.5543/tkda.2017.99165
12. Mamutov R.S., Mamaradjapova D.A. The prognostic importance ofrisk factors and medical history data on the mortality of patients of stable angina at 5 years prospective study (fragment of the register ACS/AMI. Eurasian Cardiology Journal. 2017; 1:44–8.
13. Yuan M-J, Pan Y-S, Hu W-G, Lu Z-G, Zhang Q-Y, Huang D et al. A pilot study of prognostic value of non-invasive cardiac parameters for major adverse cardiac events in patients with acute coronary syndrome treated with percutaneous coronary intervention. International Journal of Clinical and Experimental Medicine. 2015;8(12):22440–9. PMID: 26885226
14. Shakhov E.B., Shakhov B.E., Petrova E.B. Determination of the stages of endovascular revascularization of the myocardium in patients with acute coronary syndrome and multivessel lesions of the venous bed. International Journal of Interventional Cardioangiology. 2017;48–49:97.
15. Berns S. A., Zykova D. S., Zykov M. V., Shmidt E. A., Yukhno E. S., Nagirnyak O.A. et al. The Role of Multifocal Atherosclerosis in Realization of New Cardiovascular Complications During One Year After Non ST-Elevation Acute Coronary Syndrome. Kardiologiia. 2013;53 (8):15–23.
16. Zykov M.V., Zykova D.S., Kashtalap V.V., Pecherina T.B., Barbarash O.L. The prognostic value of peripheral arteries diseases in patients with st-segment elevation myocardial infarction. Atherosclerosis. 2012;8 (1):14–20.
17. Selvasandran K, Makhoul G, Jaiswal PK, Jurakhan R, Li L, Ridwan K et al. A Tumor Necrosis Factor-α and Hypoxia-Induced Secretome Therapy for Myocardial Repair. The Annals of Thoracic Surgery. 2018;105(3):715–23. DOI: 10.1016/j.athoracsur.2017.09.005
18. The International Genome Sample Resource. 1000 Genomes. A Deep Catalog of Human Genetic Variation.Available at: https://www.internationalgenome.org/home
19. Ikeda S, Tanaka N, Arai T, Chida K, Muramatsu M, Sawabe M. Polymorphisms of LTA, LGALS2, and PSMA6 genes and coronary atherosclerosis: A pathological study of 1503 consecutive autopsy cases. Atherosclerosis. 2012;221(2):458–60. DOI: 10.1016/j.atherosclerosis.2012.01.003
20. Shmidt E.A., Berns S.A., Zhidkova I.I., Makeeva O.A., Goncharova I.A., Nagirnyak O.A. et al. Association of a lymphotoxin-α variable site rs1041981 with development of long-term unfavorable outcomes in patients with acute coronary syndrome without ST-segment elevation. Medical Immunology. 2018;20(1):73–84.. DOI: 10.15789/1563-0625-2018-1-73-84
21. Kutikhin A.G., Sinitsky M.Yu., Ponasenko A.V. The role of mutagenesis in atherosclerosis. Complex Issues of Cardiovascular Diseases. 2017; 1:92–101.. DOI: 10.17802/2306-1278-2017-1-92-101
22. Lozhkina N.G., Khasanova M.H., Kuimov A.D., Tsygankova O.V., Ragino Yu.I., Maksimov V.N. et al. Multifactorial Prognostication of Remote Outcomes in Patients with Non-ST Elevation Acute Coronary Syndrome. Kardiologiia. 2017;17 (8):28–33.. DOI: 10.18087/cardio.2017.8.10014
23. Konenkov V.I., Poveshchenko O.V., Prokofiev V.F., Shevchenko A.V., Kim I.N., Bondarenko N.A. et al. The analysis of clinical, functional, laboratory and genetic parameters values on the condition of patients after myocardial infarction, and prognosis of intramyocardial autologic cell therapy effectiveness for chronic heart failure. Cardiovascular Therapy and Prevention. 2015;14 (1):23–9.. DOI: 10.15829/1728-8800-2015-1-23-29
24. Guo P, Harris R. The effectiveness and experience of self-management following acute coronary syndrome: A review of the literature. International Journal of Nursing Studies. 2016; 61:29–51. DOI: 10.1016/j.ijnurstu.2016.05.008
25. Eshah NF. Predischarge education improves adherence to a healthy lifestyle among Jordanian patients with acute coronary syndrome: Predischarge education improves lifestyle. Nursing & Health Sciences. 2013;15(3):273–9. DOI: 10.1111/nhs.12018